Metabolism and biochemical/physiological roles of chondroitin sulfates: analysis of endogenous and supplemental chondroitin sulfates in blood circulation

被引:39
作者
Lamari, Fotini N.
Theocharis, Achilleas D.
Asimakopoulou, Athanasia P.
Malavaki, Christina J.
Karamanos, Nikos K. [1 ]
机构
[1] Univ Patras, Dept Chem, Biochem Lab, Patras 26500, Greece
[2] Univ Patras, Dept Pharm, Lab Pharmacognosy & Chem Nat Prod, Patras 26500, Greece
关键词
chondroitin sulfate; metabolism; blood serum/plasma; analysis; HPLC; electrophoresis;
D O I
10.1002/bmc.669
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Chondroitin sulfate (CS) is a linear heteropolysaccharide consisting of repeating disaccharide units of glucuronic acid and galactosamine, which is commonly sulfated at C-4 and/or C-6 of galactosamine. The administration of CS as a supplement or a drug for the treatment of osteoarthrosis, the prevention of subsequent coronary events, treatment of psoriasis and ophthalmic diseases has been suggested. Much debate on the metabolism of CS and therefore the effectiveness of these treatments, especially after oral administration, has arisen due to the macromolecular nature of CS. Difficulties in analysing CS in blood due to the low endogenous concentrations and the covalent and anionic complexes with proteins have hampered the resolution of these issues. In this review, the information on the pharmacokinetics of CS obtained from studies in experimental animals and in humans is presented. Emphasis has been given to the analytical methods used for the determination of glycosaminoglycans, intact CS and CS-derived disaccharides in blood serum and plasma. Copyright (c) 2006 John Wiley & Sons, Ltd.
引用
收藏
页码:539 / 550
页数:12
相关论文
共 78 条
[1]   The bioavailability and pharmacokinetics of glucosamine hydrochloride and low molecular weight chondroitin sulfate after single and multiple doses to beagle dogs [J].
Adebowale, A ;
Du, JP ;
Liang, ZM ;
Leslie, JL ;
Eddington, ND .
BIOPHARMACEUTICS & DRUG DISPOSITION, 2002, 23 (06) :217-225
[2]   NEW DERMATAN POLYSULFATE, CHONDROITIN SULFATE H, FROM HAGFISH NOTOCHORD [J].
ANNO, K ;
SENO, N ;
MATHEWS, MB ;
YAMAGATA, T ;
SUZUKI, S .
BIOCHIMICA ET BIOPHYSICA ACTA, 1971, 237 (01) :173-&
[3]   PLASMA POLYSACCHARIDE FRACTION CONTAINING URONIC ACID, IN NORMAL SUBJECTS AND IN PATIENTS WITH RHEUMATOID ARTHRITIS [J].
BADIN, J ;
SCHUBERT, M ;
VOURAS, M .
JOURNAL OF CLINICAL INVESTIGATION, 1955, 34 (08) :1317-1323
[4]   Biochemical basis of the pharmacologic action of chondroitin sulfates on the osteoarticular system [J].
Bali, JP ;
Cousse, H ;
Neuzil, E .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2001, 31 (01) :58-68
[5]  
Barthe L, 2004, ARZNEIMITTELFORSCH, V54, P286
[7]   A MODIFIED URONIC ACID CARBAZOLE REACTION [J].
BITTER, T ;
MUIR, HM .
ANALYTICAL BIOCHEMISTRY, 1962, 4 (04) :330-&
[8]   Quantitation of proteoglycans as glycosaminoglycans in biological fluids using an alcian blue dot blot analysis [J].
Björnsson, S .
ANALYTICAL BIOCHEMISTRY, 1998, 256 (02) :229-237
[9]   NEW METHOD FOR QUANTITATIVE-DETERMINATION OF URONIC ACIDS [J].
BLUMENKR.N ;
ASBOEHAN.G .
ANALYTICAL BIOCHEMISTRY, 1973, 54 (02) :484-489
[10]   ACID MUCOPOLYSACCHARIDES IN NORMAL SERUM [J].
BOLLET, AJ ;
SERAYDARIAN, MW ;
SIMPSON, WF .
JOURNAL OF CLINICAL INVESTIGATION, 1957, 36 (09) :1328-1332